Author name: Prashant Reddy

T. Prashant Reddy graduated from the National Law School of India University, Bangalore, with a B.A.LLB (Hons.) degree in 2008. He later graduated with a LLM degree (Law, Science & Technology) from the Stanford Law School in 2013. Prashant has worked with law firms in Delhi and in academia in India and Singapore. He is also co-author of the book Create, Copy, Disrupt: India's Intellectual Property Dilemmas (OUP).

Guest Post: The legality of ‘reverse payments’ in the E.U.

The issue of reverse payments, appears to be a rather hot topic this year, with both the U.S. and the E.U. cracking down on this practice, where an innovator pharmaceutical company, which owns a patent, pays off a generic competitor to not enter the market. Last week we had a guest post by George Yu, on the U.S. Supreme Court’s decision in the Acatavis case. Today we have for our readers a guest post by Gary Moss, a U.K. solicitor, […]

Guest Post: The legality of ‘reverse payments’ in the E.U. Read More »

Guest Post: Kerala’s Endosulfan Ban – The science that never got discussed

We have for our readers today, a post by an award-winning journalist, Priyanka Pulla who has previously blogged for us over here on Ayurvedic medicines. She was recently awarded the first prize in the Science and Innovation category of the RedInk Awards for Journalism, 2013 for this story on Flock Theory and the Synchronies of Nature, published in Open, over here. One of her more recent stories in Open Magazine, available over here, was on the Endosulfan tragedy where she

Guest Post: Kerala’s Endosulfan Ban – The science that never got discussed Read More »

Patent Office publishes all ‘Statements of Working’ – Finally!

In a very welcome development, the Patent Office, for the very first time in its history, has made available all of the “Statements of Working” filed by all patentees for the year 2012. You can view the information over here. Every year, under Section 146, the Controller General calls on patentees to submit in Form 27 information pertaining to the working of the patent. In this Form 27, the Patent Office usually asks for information on whether the patent is

Patent Office publishes all ‘Statements of Working’ – Finally! Read More »

SpicyIP Jobs: Lawyers Collective seeks to recruit lawyers for its HIV/AIDS Unit

Lawyers Collective seeks to recruit three legal officers for the HIV/AIDS Unit in New Delhi. The job profile includes excellent opportunities for drafting, filing and making appearances at various patent controllers’ offices for pre and post grant patent oppositions. The post is open to entry level professionals as well as those having 2 to 3 years of experience in the field of pharmaceutical patent law. Preference will be given to those with a sound background in organic chemistry, biochemistry, pharmaceutical

SpicyIP Jobs: Lawyers Collective seeks to recruit lawyers for its HIV/AIDS Unit Read More »

Guest Post: U.S. Supreme Court rules on the legality of ‘Reverse-Payment’ settlements

Earlier this week, the U.S. Supreme Court finally delivered a long awaited opinion in the Actavis case, regarding the legality of reverse-payment settlements, where generic pharmaceutical companies accept payments to withdraw Hatch-Waxman challenges to patents owned by innovators.  We had earlier covered the oral arguments, in a guest post by George Yu, an experienced patent litigator with Schiff-Hardin LLP. You can read that post over here. Geroge was kind enough to write us another post providing us with an analysis

Guest Post: U.S. Supreme Court rules on the legality of ‘Reverse-Payment’ settlements Read More »

Guest Post: The opinion of the U.S. Supreme Court in the Myriad case

As many of you may have already heard, the U.S. Supreme Court recently issued a ruling on whether human genes could be patented. We had covered this issue at the stage of arguments in two guest posts, over here and here. One of our regular guest bloggers, Chris Ohly, a partner at a leading U.S. law firm has been kind enough to send us a guest post, analysing the latest opinion of the U.S. Supreme Court in this case. The

Guest Post: The opinion of the U.S. Supreme Court in the Myriad case Read More »

Indian start-up complains about unfair Google Ad-Sense contracts

For several years now the Google Empire has been built on the fabulous success of its Ad-Sense program, which places relevant advertisements during the search results on the Google search engine and also on third-party websites. Google usually charges the advertiser only when a user clicks on the advertisement. Inevitably, as is always the case with Google, the program faced more than its share of legal challenges, especially multiple lawsuits for the infringement of trademarks. Recently, Kashyap a school-friend of

Indian start-up complains about unfair Google Ad-Sense contracts Read More »

Guest Post: Impugning novelty the Novartis way

Carrying on with our lively debate on the merits of the Supreme Court’s judgement in the Novartis case, Siva Thambisetty has sent us this reply to Darren’s rejoinder, which we had published over here. This is the first time we’ve had such an extended debate on the blog and I hope we can have more such debate on other aspects of IP law.  For the earlier exchange between Darren and Siva, please click over here, here and here. Impugning novelty

Guest Post: Impugning novelty the Novartis way Read More »

The Times Publishing House threatens to sue our blogger for alleged defamation – we ain’t going down without a fight!

Aparajita Lath – SpicyIP Blogger Take a good hard look at the photograph on the right. It’s a photograph of one of our youngest bloggers – Aparajita Lath, an innocent 22 year old gifted law student at the National University of Juridical Sciences (NUJS), one of the top law schools in India. Do you think this girl is capable of hurting anybody much less defame one of the largest media companies in India? Well, apparently there is somebody either at

The Times Publishing House threatens to sue our blogger for alleged defamation – we ain’t going down without a fight! Read More »

Guest Post: A rejoinder from the IPKat

Continuing with our debate, between Darren Smyth of IPKat fame and Siva Thambisetty, on the merits of the Supreme Court’s decision in the Novartis case, we have for our readers a rejoinder from Darren in response to Siva’s last post on this issue. The two previous posts on this issue can be accessed over here and here.  A Rejoinder from the IPKat,  by Darren Smyth  I was very interested to read the thoughts of Siva Thambisetty. However, with the greatest

Guest Post: A rejoinder from the IPKat Read More »

Scroll to Top